Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aptorum Group Ltd Cl A
(NQ:
APM
)
3.100
+0.080 (+2.65%)
Streaming Delayed Price
Updated: 11:59 AM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aptorum Group Ltd Cl A
< Previous
1
2
3
4
5
6
7
Next >
Aptorum Group Limited Announces Results of 2022 Annual General Meeting of Shareholders
December 22, 2022
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Announces Completion of $3 Million Convertible Note due 2023
December 16, 2022
From
Aptorum Group Limited
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 09, 2022
Via
Benzinga
Aptorum Group Announces Offering of $3 Million Convertible Note due 2023
December 09, 2022
From
Aptorum Group Limited
Via
Business Wire
HC Wainwright Initiates Aptorum On Upcoming "Innovative Pipeline"
October 07, 2022
Via
Benzinga
Aptorum Highlights Updates On Clinical Validation of RPIDD Infectious Disease Molecular Diagnostics
September 15, 2022
Via
Benzinga
Aptorum Group Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
November 25, 2022
Via
ACCESSWIRE
Aptorum Announces Publication of a Co-authored Paper on Development and Validation of a Sensitive Liquid Chromatography with Time-Of-Flight Mass Spectrometry Assay for In Vivo Pharmacokinetic Study of Epigallocatechin-gallate octaacetate (Pro-EGCG)
November 25, 2022
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
November 18, 2022
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 21, 2022
November 08, 2022
From
Aptorum Group Limited
Via
Business Wire
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Gainers
Via
Benzinga
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
November 04, 2022
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022
October 07, 2022
Upgrades
Via
Benzinga
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
November 04, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 07, 2022
Gainers Akanda (NASDAQ:AKAN) stock rose 27.1% to $0.52 during Friday's pre-market session. The company's market cap stands at $16.0 million.
Via
Benzinga
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2022
September 30, 2022
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
September 23, 2022
Via
ACCESSWIRE
Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in Hong Kong
September 15, 2022
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics
September 15, 2022
From
Aptorum Group Limited
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 02, 2022
Via
Benzinga
7 Hot Small-Cap Stocks to Buy in September
September 02, 2022
It's easier to make huge profits with hot small-cap stocks than with large-cap ones. Here are seven promising small-cap stocks to buy.
Via
InvestorPlace
Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket
September 02, 2022
Gainers
Via
Benzinga
Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022
August 25, 2022
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
August 19, 2022
Via
ACCESSWIRE
The Global Pharmaceutical Industry is Accelerating; Aptorum Group Has Received Orphan Drug Designation from US FDA for Its SACT-1
July 25, 2022
Via
ACN Newswire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Product Safety
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
July 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Aptorum Group Limited to Present at the H.C. Wainwright Global Investment Conference, May 23 – 26 2022
May 17, 2022
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targeting neuroblastoma
May 02, 2022
From
Aptorum Group Limited
Via
Business Wire
Aptorum Group Limited Reports 2021 Fiscal Year End Financial Results and Provides Business Update
April 29, 2022
From
Aptorum Group Limited
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.